News
A new NDA was submitted in January 2024, which the FDA did accept, and that was later converted into a priority review. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback